Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Regine Grosse, MD, Suzan Acar, Bjoern Schoennagel, MD, Roland Fischer, PhD, Jin Yamamura, MD, Gritta Janka, MD PhD, Peter Nielsen, MD

Blood (2015) 126 (23): 3358.

https://doi.org/10.1182/blood.V126.23.3358.3358

Published: 2015

Journal Articles

Pancreatic Iron and Fat Infiltration Are Diabetogenic Risk Factors In Patients With Iron Overload

Regine Grosse, MD, Charlotte Pfeiffer, Bjoern P Schoennagel, MD, Gritta E. Janka, MD, PhD, Peter Nielsen, MD, Roland Fischer, PhD, Jin Yamamura, MD

Blood (2013) 122 (21): 2204.

https://doi.org/10.1182/blood.V122.21.2204.2204

Published: 2013

Journal Articles

Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study)

John Porter, MD, Patrick B Walter, PhD, Lynne D Neumayr, MD, Patricia Evans, PhD, Marcela G Weyhmiller, PhD, Paul Harmatz, MD, John C. Wood, MD, PhD, Jeffery L Miller, MD, Guenter Weiss, MD, Quing Yuan, PhD, Zhiyue J Wang, PhD, Regine Grosse, MD, Bjoern P Schoennagel, MD, Joerg Meerpohl, MD, Roland Fischer, PhD, Peter Nielsen, MD, Markus Seifert, BSc, Elliott Vichinsky, MD

Blood (2013) 122 (21): 1014.

https://doi.org/10.1182/blood.V122.21.1014.1014

Published: 2013

Journal Articles

A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene

Bernard Grandchamp, Gilles Hetet, Caroline Kannengiesser, Claire Oudin, Carole Beaumont, Sylvie Rodrigues-Ferreira, Robert Amson, Adam Telerman, Peter Nielsen, Elisabeth Kohne, Christina Balser, Hermann Heimpel

Blood (2011) 118 (25): 6660–6666.

https://doi.org/10.1182/blood-2011-01-329011

Published: 2011

Includes: Supplemental data

Journal Articles

Measurement of Liver Iron Concentration by Quantum Interference Device Biosusceptometry (SQUID) Validates Serum Ferritin As Prognostic Parameter for Allogeneic Stem Cell Transplantation

Nicole Jacobi, MD, MS, Regine Grosse, MD, Tugce Aktas, Lena Herich, Peter Nielsen, MD, Roland Fischer, PhD, Tatjana Zabelina, Ulrike Bacher, MD, Nicolaus Kroeger, Sr., MD

Blood (2011) 118 (21): 1018.

https://doi.org/10.1182/blood.V118.21.1018.1018

Published: 2011

Journal Articles

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Regine Grosse, MD, Andrea Jarisch, PhD, MD, Jin Yamamura, MD, Peter Nielsen, MD, Roland Fischer, PhD, Gritta Janka, MD, PhD

Blood (2011) 118 (21): 2110.

https://doi.org/10.1182/blood.V118.21.2110.2110

Published: 2011

Journal Articles

Deferasirox (Exjade®) Given During Conditioning Regimen (FLAMSA/Busulfan/ATG) Reduces the Appearance of Labile Plasma Iron in Patients Undergoing Allogeneic Stem Cell Transplantation

Annekathrin Fritsch, Claudia Langebrake, PhD, Peter Nielsen, MD, Ulrike Bacher, MD, Michael Baehr, PhD, Dorothee C. Dartsch, PhD, Nicolaus Kroeger, M.D.

Blood (2011) 118 (21): 3023.

https://doi.org/10.1182/blood.V118.21.3023.3023

Published: 2011

Journal Articles

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Regine Grosse, Gritta Janka, MD, PhD, Andrea Jarisch, PhD, MD, Peter Nielsen, Jin Yamamura, Roland Fischer, PhD

Blood (2010) 116 (21): 5168.

https://doi.org/10.1182/blood.V116.21.5168.5168

Published: 2010

Journal Articles

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Roland Fischer, PhD, Regine Grosse, Rainer Engelhardt, PhD, Peter Nielsen, PhD, MD, Oliver Leismann, PhD, Gritta E. Janka, MD

Blood (2007) 110 (11): 2776.

https://doi.org/10.1182/blood.V110.11.2776.2776

Published: 2007

Journal Articles

Chelator Efficacy of Deferasirox and Deferoxamine Determined by SQUID Biosusceptometry.

Regine Grosse, Gisela Janssen, Rainer Engelhardt, Marketa Groeger, Oliver Leismann, Peter Nielsen, Roland Fischer, Gritta Janka

Blood (2006) 108 (11): 1779.

https://doi.org/10.1182/blood.V108.11.1779.1779

Published: 2006

Journal Articles

Iron Stores in Patients with Myelodysplasia and Aplastic Anemia.

Peter Nielsen, Tim H. Bruemmendorf, Regine Grosse, Rainer Engelhardt, Nicolaus Kroeger, Hartmut Kabisch, Oliver Leismann, Roland Fischer, Axel R. Zander

Blood (2006) 108 (11): 3726.

https://doi.org/10.1182/blood.V108.11.3726.3726

Published: 2006

Journal Articles

Does liver biopsy overestimate liver iron concentration?

Roland Fischer, Paul Harmatz, Peter Nielsen

Blood (2006) 108 (5): 1775–1776.

https://doi.org/10.1182/blood-2006-03-013482

Published: 2006

Journal Articles

Does liver biopsy overestimate liver iron concentration?

Roland Fischer, Paul Harmatz, Peter Nielsen

Blood (2006) 108 (2): 778.

https://doi.org/10.1182/blood-2006-03-009167

Published: 2006

Journal Articles

Serum Ferritin and Liver Iron Concentration in Patients with Iron Overload.

Zahra Pakbaz, MD, Roland Fischer, PhD, Ellen Fung, PhD, Peter Nielsen, PhD, MD, Rainer Engelhardt, PhD, Paul Harmatz, MD, Elliott Vichinsky, MD

Blood (2005) 106 (11): 3833.

https://doi.org/10.1182/blood.V106.11.3833.3833

Published: 2005

Journal Articles

Comparison of Liver Iron Concentration Measured by the SQUID Biosusceptometers at Hamburg, Torino and Oakland in Patients with Thalassemia and Sickle Cell Disease.

Ellen B. Fung, PhD, RD, Filomena Longo, MD, Roland Fischer, PhD, Rainer Engelhardt, PhD, Zahra Pakbaz, MD, Herbert Optiz, PhD, Robert L. Fagaly, PhD, Hanspeter Nick, PhD, Peter Nielsen, MD, PhD, Elliott Vichinsky, MD, Antonio Piga, MD, Paul Harmatz, MD

Blood (2005) 106 (11): 3721.

https://doi.org/10.1182/blood.V106.11.3721.3721

Published: 2005

NARROW

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Pancreatic Iron and Fat Infiltration Are Diabetogenic Risk Factors In Patients With Iron Overload

Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study)

A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene

Measurement of Liver Iron Concentration by Quantum Interference Device Biosusceptometry (SQUID) Validates Serum Ferritin As Prognostic Parameter for Allogeneic Stem Cell Transplantation

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Deferasirox (Exjade®) Given During Conditioning Regimen (FLAMSA/Busulfan/ATG) Reduces the Appearance of Labile Plasma Iron in Patients Undergoing Allogeneic Stem Cell Transplantation

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Chelator Efficacy of Deferasirox and Deferoxamine Determined by SQUID Biosusceptometry.

Iron Stores in Patients with Myelodysplasia and Aplastic Anemia.

Does liver biopsy overestimate liver iron concentration?

Does liver biopsy overestimate liver iron concentration?

Serum Ferritin and Liver Iron Concentration in Patients with Iron Overload.

Comparison of Liver Iron Concentration Measured by the SQUID Biosusceptometers at Hamburg, Torino and Oakland in Patients with Thalassemia and Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only